Antiretrovirals Flashcards
what are the 5 nucleoside reverse transcriptase inhibitors
zidovudine, emtricitabine, tenofovir, lamivudine, abacavir
MOA of NRTIS
requires phosphorlyation x 3, incorporated into viral DNA and inhibits viral reverse transcriptase
zidovudine, good for what patients?
AIDS dementia (CNS penetration) and safe in pregnancy
zidovudine toxicity
CNS, lactic acidosis, hepatoxicity, myelosuppresion
first line NRTS for HIV
tenofovir and emtricitabine
side effects of tenofovir and emtricitabine
flatulence
toxicity of abacavir
serious hypersensitivity, SJS so screen for HLA-B-5701, cannot restart drug if every go off, is usually fatal
what are the two NNRTIs
efavirenz and rilpivirine
MOA for NNRTIs
binds directly to inhibit viral reverse transcriptase
toxicities of efavirenz
drug interactions (CYP3A4), teratogenic so avoid in pregnancy
DOC for NNRTIs
efavirenz, use rilpivirine if pregnant
protease inhibitors
all end in ivir, except abacavir which is an NRTIs
protease inhibitors MOA
bind to proteases inhibiting their function (digestion of long polypeptides into smaller mature ones)
must give a protease inhibitor with what other drug
NRTIs, due to mutations and resistance if given alone
common toxicities of protease inhibitors
altered body fat distribution, insulin resistance, elevated serum cholesterol, spontaneous bleeding
drug interactions of PIs
metabolized by CYP3A4 so often given with ritonavir to increase blood levels and decrease dosing, do not give with drugs that induce CYP3A4 because it will decrease levels (aka RIFAMPIN, St. John’s wort)
toxicities of ritonavir
do not combine with saquinavir, QT
contains ethanol, do not give with disulfiram, flagyl, cephalosporins
PI DOC
darunavir
limits to darunavir and tipranavir
contains a sulfa moiety, do not use in patients with an allergy to sulfa
PI drug of second choice
atazenavir
side effects of atazenavir
diarrhea, rash, nausea is common, may cause an increase in bilirubin
what drug is lopinavir given with
ritonavir, increases bioavailability
why do we not give indinavir often
cross resistance with ritonavir, nephrolithiasis, hyperbilirubienia
who should be given tipranavir
treatment experienced pateints
what are the two fusion inhibitors
enfuvirtide, maraviroc
MOA of enfuvirtide
binds to gp41 subunit and prevents conformational change
enfuvirtide
only for treatment experienced patients, SQ only, increases chance of bacterial pneumonia
maravoic MOA
CCR5 binding to inhibit fusion
MOA for dolutegravir
integrase inhibitor